Showing results (411-420 of 446) with videos related to
Sort By:
Pageof 45
The New England Journal of Medicine|June 10, 2008
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, Anushka Patel, Stephen MacMahon, et al.JAMA|August 31, 2024
Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical TrialDike B Ojji, Abdul Salam, Mahmoud U Sani, et al.The Lancet. HIV|September 19, 2017
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trialPedro Cahn, Richard Kaplan, Paul E Sax, et al.Lancet (London, England)|February 14, 2017
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic reviewClara K Chow, Jay Thakkar, Alex Bennett, et al.Journal of Clinical Epidemiology|November 25, 2022
Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issuesYing Wang, Maryam Ghadimi, Qi Wang, et al.Circulation|May 9, 2022
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical TrialClara K Chow, Harry Klimis, Aravinda Thiagalingam, et al.The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.American Heart Journal|July 21, 2023
Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocolSonali R Gnanenthiran, Isabella Tan, Emily R Atkins, et al.Trials|October 24, 2023
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorderOrli S Schwartz, Paul Amminger, Bernard T Baune, et al.Trials|April 29, 2026
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic riskPhyo Pyae Nyein, Hila Haskelberg, Marianne Martinello, et al.Pageof 45